Three insights:
1. Valuation multiples with median total invested capital to trailing 12-month EBITDA multiples were about 7.4x in 2018, down from 7.7x in 2019.
2. ASCs that perform newly Medicare-reimbursed total joint and cardiac catheterization procedures will be acquisition targets with leverage to negotiate higher transaction multiples.
3. Involvement in bundled payment programs will also make ASCs acquisition targets.
More articles on surgery centers:
4 COVID-19 supply considerations for ASCs
5 hospitals, health systems opening or planning ASCs
ASCs reopening to patients: Check these 7 boxes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
